Buy Lupin with a target price of Rs 815: Prakash Gaba

Pharma stocks like Dr Reddys Labs, Divis Labs, Biocon, Sun Pharma and Lupin will be getting astrological support, says Satish Gupta of Astrostocktips.

Sun, Lupin and Dr Reddy’s to lead here, with domestic formulations expected to rebound after Sept quarter. After posting a strong 20-plus per cent growth in the March quarter, top Indian pharmaceutical companies are expected to show similar growth in 2013-14. While the momentum is likely to come from the US market, the revival in domestic business should also help overall revenue growth.Manoj Garg and Perin Ali of Edelweiss Securities say revenue growth should sustain at double digits in ...

One should go long in Lupin and expect a big upswing in the coming days, feels Sudarshan Sukhani of s2analytics.com.

ITC, Axis Bank and Lupin are among the India's top 10 most competitive companies, according to Japanese broking firm Nomura. Identified developing a quantitative framework, these companies have delivered above-average business returns, which has driven their ...

BofA-ML feels that most of the depreciation may be behind us as; gold imports are reducing and likely to fall. NEW DELHI: Indian rupee which has depreciated over 6 per cent in the past one month is likely to have limited impact on companies which have foreign ...

Interview with CEO-designate, Lupin Pharmaceuticals email this article Subject line: Your Email: Send me a copy: Recipients Id: Type address separated by commas Enter the characters shown in the image. Send Lupin, India’s third-largest pharmaceuticals ...

While most stocks have corrected and are below 200- Daily Moving Averages, Lupin is showing strength as weakness in rupee augurs well for it. MUMBAI: While most stocks have corrected and are below 200- Daily Moving Averages, Lupin is showing strength as ...

We at Myiris have collated intra-day technical calls from various brokers. The same are mentioned below: ICICIdirect 1. Lupin 'Buy' above Rs 776 with target of Rs 788.00-794 higher and stop loss Rs 770. Comment: Trend line breakout in the daily chart and ...

He further added, Sun Pharma is leading there and we believe more upside there along with smaller players like Lupin. However we continue to remain bullish on Sun Pharma and we see further upside from here. So Sun Pharma could be a hold. People who ...